Category: Danaher Corp.Syndicate content

Danaher becomes dental giant with $2.1B Nobel Biocare buy

September 15, 2014 by Arezu Sarvestani

The $2.14 billion acquisition of Nobel Biocare will turn Danaher into the largest dental implants provider in the world.

Danaher becomes dental giant with $2.1B Nobel Biocare buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien acquires Reverse Medical | Medtech Wall Street news for the week of August 25, 2014

August 28, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Covidien snaps up Reverse Medical; Standard & Poor's maintains credit watch on Medtronic over Covidien buy; Allergan can't delay shareholder vote on hostile Valeant bid; Medtronic drops $200M on Dutch DBS firm Sapiens; Nobel Biocare's Q2 profits double as it fields buyout interest

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

YYmeta

Nobel Biocare's Q2 profits double as it fields buyout interest

August 21, 2014 by Brad Perriello

Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.

Nobel Biocare's Q2 profits double as it fields buyout interest

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

JNJ looks to bolster "subscale" cardiovascular business | The week in medtech M&A

July 23, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

YYmeta

Siemens sells clinical microbiology biz to Beckman Coulter

July 17, 2014 by Arezu Sarvestani

Beckman Coulter picks up Siemens Healthcare Diagnostics' clinical microbiology business in a closed-doors deal.

Siemens sells clinical microbiology biz to Beckman Coulter

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Danaher, Blackstone join forces in hunt for J&J diagnostics unit

November 8, 2013 by Brad Perriello

Danaher Corp. and private equity behemoth Blackstone are joining forces in the hunt for Johnson & Johnson's Ortho Clinical Diagnostics unit, anonymous sources tell Reuters.

Report: Danaher, Blackstone join forces in hunt for J&J diagnostics unit

Danaher climbs on Q3 numbers

October 17, 2013 by Brad Perriello

Shares of Danaher Corp. rise after it beats Wall Street's earnings forecast and affirms its outlook for the rest of the year.

Danaher climbs on Q3 numbers

Danaher (NYSE:DHR) shares gained today after the conglomerate shattered Wall Street's 3rd-quarter earnings expectations and affirmed its outlook for the balance of 2013.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp